Acute coronary syndromes: 6c-Patients discharged on lipid-lowering therapy
Indicator Attributes
Identifying and definitional attributes | |
Metadata item type: | Indicator |
|---|---|
| Indicator type: | Indicator |
| Short name: | Indicator 6c-Patients discharged on lipid-lowering therapy |
| METEOR identifier: | 612087 |
| Registration status: | Health, Standard 12/09/2016 |
| Description: | Proportion of patients with a final diagnosis of acute coronary syndrome (ACS) who are prescribed lipid-lowering therapy at separation from hospital. |
| Rationale: | Lowering lipid levels (using statins) is an effective primary and secondary prevention treatment for vascular events, including stroke (Amarenco et al. 2006). |
| Indicator set: | Clinical care standard indicators: acute coronary syndromes Health, Standard 12/09/2016 |
| Outcome area: | Individualised care plan Health, Standard 12/09/2016 |
Collection and usage attributes | |
| Computation description: | Both the numerator and the denominator include patients with acute chest pain, or other symptoms suggestive of ACS. The denominator excludes statin-intolerant ACS patients, and other ACS patients for whom statins or other lipid-lowering therapies are contraindicated and for whom the contraindication is documented. Contraindications for statins may include advance care directives, being on a palliative care pathway, and clinical judgement, subject to discussion with patients, family and carers. Presented as a percentage. |
|---|---|
| Computation: | (Numerator ÷ denominator) x 100 |
| Numerator: | Number of patients with a final diagnosis of ACS who are prescribed a statin or other lipid-lowering therapy at separation from hospital. |
| Denominator: | Number of patients with a final diagnosis of ACS who are separated from hospital. |
Representational attributes | |
| Representation class: | Percentage |
| Data type: | Real |
| Unit of measure: | Episode |
| Format: | N[NN] |
Source and reference attributes | |
| Submitting organisation: | Australian Commission on Safety and Quality in Health Care |
| Reference documents: | Amarenco P et al. 2006. High-dose atorvastatin after stroke or transient ischemic attack. New England Journal of Medicine 355(6):549–559. |